Cargando…

Rituximab is a therapeutical option for juvenile microscopic polyangiitis

Detalles Bibliográficos
Autores principales:	Brunner, J, Freund, M, Prelog, M, Binder, E, Sailer-Höck, M, Jungraithmayr, T, Mayer, G, Zimmerhackl, LB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334076/ http://dx.doi.org/10.1186/1546-0096-6-S1-P268

Ejemplares similares

Analysis of the classical, alternative, and MBL pathways of the complement system in juvenile idiopathic arthritis
por: Brunner, J, et al.
Publicado: (2008)

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis
por: Brogan, Paul, et al.
Publicado: (2021)

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis
por: Jamois, Candice, et al.
Publicado: (2022)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
por: Melega, Simone, et al.
Publicado: (2022)

PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis
por: Noergaard, M, et al.
Publicado: (2013)

PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis
por: Twilt, M, et al.
Publicado: (2013)

The effect of Rituximab treatment on T cells
por: Diaz-Torné, C, et al.
Publicado: (2010)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
por: Harigai, Masayoshi, et al.
Publicado: (2019)

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003)

The therapeutic value of low-energy laser (LLLT) for enthesitis in children with juvenile spondyloarthropathies
por: Harjacek, M, et al.
Publicado: (2008)

Update on the juvenile systemic sclerosis inception cohort http://www.juvenile-scleroderma.com
por: Foeldvari, Ivan, et al.
Publicado: (2014)

Complement analysis reveals new biomarkers in patients with juvenile idiopathic arthritis
por: Brunner, Juergen, et al.
Publicado: (2014)

Potential biomarkers and therapeutic targets in juvenile spondyloarthritis patients
por: Lamot, Lovro, et al.
Publicado: (2014)

A292 ACUTE PANCREATITIS AS THE FIRST PRESENTATION OF GRANULOMATOSIS WITH POLYANGIITIS (GPA): A CASE REPORT
por: Youssef, M, et al.
Publicado: (2023)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

Microscopic Polyangiitis in Systemic Sclerosis
por: Hashimoto, Hiroshi
Publicado: (2010)

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
por: Sugiyama, Koichi, et al.
Publicado: (2012)

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis
por: Samson, Maxime, et al.
Publicado: (2023)

Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis
por: Villeneuve, Thomas, et al.
Publicado: (2023)

Changes in nailfold videocapillaroscopy in patients with granulomatosis with polyangiitis (Wegener’s): an observational study
por: Uceda, Julia, et al.
Publicado: (2012)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis
por: Endo, Yushiro, et al.
Publicado: (2018)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Deep vein thrombosis: An unusual way of revealing microscopic polyangiitis. Deep vein thrombosis in microscopic polyangiitis
por: Jerbi, Mouna, et al.
Publicado: (2020)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
por: Nakade, Issei, et al.
Publicado: (2023)

Eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome) without respiratory symptoms in a boy
por: Yüksel, Selçuk, et al.
Publicado: (2014)

PReS-FINAL-2321: Clinical manifestations of granulomatosis with polyangiitis in 8 children from south-east region of Poland
por: Kosałka, J, et al.
Publicado: (2013)

Microscopic polyangiitis associated with subarachnoid hemorrhage
por: Ihara, Katsuhito, et al.
Publicado: (2019)

Microscopic Polyangiitis Initially Presumed to Be Endocarditis
por: Kaneko, Takahiro, et al.
Publicado: (2020)

Eosinophilic granulomatosis with polyangiitis with severe pulmonary hemorrhage treated with rituximab
por: Baikunje, S., et al.
Publicado: (2016)

Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008)

Safety of rituximab in children with auto-immune diseases
por: Bader-Meunier, B, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_besm7047nugtmtqkusarf4r3ah